logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
S

Shen, Lin

Peking University
H指数:0
被引数:2

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical Benefit of Avapritinib in KIT-Mutant Gastrointestinal Stromal Tumors: A Post Hoc Analysis of the Phase I NAVIGATOR and Phase I/II CS3007-001 Studies

阿维替尼在KIT突变胃肠道间质瘤中的临床益处: I期导航和I/II期CS3007-001研究的事后分析

CLINICAL CANCER RESEARCH
IF10.2
2023-11-300
PRE
Heinrich, Michael C.; Zhang, Xinhua; Jones, Robin L.; George, Suzanne; Serrano, Cesar; Deng, Yanhong; Bauer, Sebastian; Cai, Shirong; Wu, Xin; Zhou, Yongjian; Tao, Kaixiong; Zheng, Zhichao; Zhang, Jun; Cui, Yuehong; Cao, Hui; Wang, Meining; Hu, Jin; Yang, Jason; Li, Jian; Shen, Lin
Non-invasive CT imaging biomarker to predict immunotherapy response in gastric cancer: a multicenter study

无创CT成像生物标志物预测胃癌免疫治疗反应的多中心研究

JOURNAL FOR IMMUNOTHERAPY OF CANCER
IF10.6
2023-11-215
OAAI
Huang, Weicai; Xiong, Wenjun; Tang, Lei; Chen, Chuanli; Yuan, Qingyu; Zhang, Cheng; Zhou, Kangneng; Sun, Zepang; Zhang, Taojun; Han, Zhen; Feng, Hao; Liang, Xiaokun; Zhong, Yonghong; Deng, Haijun; Yu, Lequan; Xu, Yikai; Wang, Wei; Shen, Lin; Li, Guoxin; Jiang, Yuming
CLDN18.2 and 4-1BB bispecific antibody givastomig exerts antitumor activity through CLDN18.2-expressing tumor-directed T-cell activation

CLDN18.2和4-1BB双特异性抗体givastomig通过表达CLDN18.2的肿瘤定向T细胞活化发挥抗肿瘤活性

JOURNAL FOR IMMUNOTHERAPY OF CANCER
IF10.6
2023-06-2616
OAAI
Gao, Jing; Wang, Zhengyi; Jiang, Wenqing; Zhang, Yanni; Meng, Zhen; Niu, Yanling; Sheng, Zhen; Chen, Chan; Liu, Xuejun; Chen, Xi; Liu, Chanjuan; Jia, Keren; Zhang, Cheng; Liao, Haiyan; Jung, Jaeho; Sung, Eunsil; Chung, Hyejin; Zhang, Jingwu Z.; Zhu, Andrew X.; Shen, Lin
Combination of AKT1 and CDH1 mutations predicts primary resistance to immunotherapy in dMMR/MSI-H gastrointestinal cancer

AKT1和CDH1突变的组合预测dMMR/msi-h胃肠道癌对免疫疗法的原发性耐药

JOURNAL FOR IMMUNOTHERAPY OF CANCER
IF10.6
2022-06-1518
OAAI
Wang, Zhenghang; Zhang, Qi; Qi, Changsong; Bai, Yuezong; Zhao, Feilong; Chen, Hui; Li, Zhongwu; Wang, Xicheng; Chen, Mifen; Gong, Jifang; Peng, Zhi; Zhang, Xiaotian; Cai, Jinping; Chen, Shiqing; Zhao, Xiaochen; Shen, Lin; Li, Jian
Randomized, Double-Blind, Placebo-Controlled Phase III Study of Paclitaxel ± Napabucasin in Pretreated Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

紫杉醇 ± Napabucasin在预处理的晚期胃或胃食管交界处腺癌中的随机，双盲，安慰剂对照III期研究

CLINICAL CANCER RESEARCH
IF10.2
2022-05-313
OAAI
Shah, Manish A.; Shitara, Kohei; Lordick, Florian; Bang, Yung-Jue; Tebbutt, Niall C.; Metges, Jean-Phillippe; Muro, Kei; Lee, Keun-Wook; Shen, Lin; Tjulandin, Sergei; Hays, John L.; Starling, Naureen; Xu, Rui-Hua; Sturtz, Keren; Fontaine, Marilyn; Oh, Cindy; Brooks, Emily M.; Xu, Bo; Li, Wei; Li, Chiang J.; Borodyansky, Laura; Van Cutsem, Eric
Efficacy and safety of weekly paclitaxel with or without ramucirumab as second-line therapy for the treatment of advanced gastric or gastroesophageal junction adenocarcinoma (RAINBOW-Asia): a randomised multicentre, double-blind, phase 3 trial
LANCET GASTROENTEROLOGY & HEPATOLOGY
IF38.6
2021-12-0151
PREAI
Xu, Rui-Hua; Zhang, Yanqiao; Pan, Hongming; Feng, Jifeng; Zhang, Tao; Liu, Tianshu; Qin, Yanru; Qin, Shukui; Yin, Xianli; Liu, Baorui; Ba, Yi; Yang, Nong; Voon, Pei Jye; Tanasanvimon, Suebpong; Zhou, Chan; Li Zhang, Wan; Shen, Lin
Germline HLA-B evolutionary divergence influences the efficacy of immune checkpoint blockade therapy in gastrointestinal cancer

生殖系hla-b进化差异影响免疫检查点阻断治疗胃肠道肿瘤的疗效

GENOME MEDICINE
IF11.2
2021-11-0310
OAAI
Lu, Zhihao; Chen, Huan; Jiao, Xi; Wang, Yujiao; Wu, Lijia; Sun, Huaibo; Li, Shuang; Gong, Jifang; Li, Jian; Zou, Jianling; Yang, Keyan; Hu, Ying; Mao, Beibei; Zhang, Lei; Zhang, Xiaotian; Peng, Zhi; Lu, Ming; Wang, Zhenghang; Zhang, Henghui; Shen, Lin
Efficacy and safety of a novel anti-HER2 therapeutic antibody RC48 in patients with HER2-overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single-arm phase II study

新型anti-HER2治疗性抗体RC48在HER2-overexpressing，局部晚期或转移性胃或胃食管交界处癌患者中的疗效和安全性: 一项单臂II期研究

CANCER COMMUNICATIONS
IF24.9
2021-10-19116
OAAI
Peng, Zhi; Liu, Tianshu; Wei, Jia; Wang, Airong; He, Yifu; Yang, Liuzhong; Zhang, Xizhi; Fan, Nanfeng; Luo, Suxia; Li, Zhen; Gu, Kangsheng; Lu, Jianwei; Xu, Jianming; Fan, Qingxia; Xu, Ruihua; Zhang, Liangming; Li, Enxiao; Sun, Yuping; Yu, Guohua; Bai, Chunmei; Liu, Yong; Zeng, Jiangzheng; Ying, Jieer; Liang, Xinjun; Xu, Nong; Gao, Chao; Shu, Yongqian; Ma, Dong; Dai, Guanghai; Li, Shengmian; Deng, Ting; Cui, Yuehong; Fang, Jianmin; Ba, Yi; Shen, Lin

研究方向

暂未获取到该数据
L
Li, Jian
H 指数:0论文数:127被引数:0
G
Gong, Jifang
H 指数:0论文数:40被引数:0
P
Peng, Zhi
H 指数:0论文数:42被引数:1
Z
Zhang, Xiaotian
H 指数:0论文数:66被引数:0
徐
徐瑞华
H 指数:104论文数:1,467被引数:5.3万
W
Wang, Zhenghang
H 指数:0论文数:19被引数:0
L
Liu, Tianshu
H 指数:0论文数:0被引数:2
L
Lu, Zhihao
H 指数:0论文数:21被引数:0
陈欢 封面图
陈欢
H 指数:65论文数:1,120被引数:2.1万
J
Jiao, Xi
H 指数:0论文数:8被引数:0